Key points are not available for this paper at this time.
Recording and classifying drugs reported in relation to suspected drug adverse reactions by fifteen countries has required the development of a special system. A comprehensive cross reference system between different types of drug names (INN, other nonproprietary names, trade names, etc.) and their occurrence in single and multiple ingredient products has been developed. Separate pharmacologic and therapeutic classifications designed for the needs of drug monitoring provide for farther special grouping. On the basis of accumulated data, some analysis is given of reporting patterns and drug profiles in different countries.
Helling et al. (Tue,) studied this question.